When I raised the concern about my appetite loss during my doctor's visit, she suggested I remind myself to eat, since that would force me to eat even when I didn't want to
Regulatory and Policy Implications: The prominence of GLP-1 drugs may necessitate revisiting and revising healthcare policies, ensuring they are aligned with the latest scientific evidence and societal needs
Semaglutide has emerged as a major player in both weight loss and diabetes management
Some people taking semaglutide may also be on other drugs that affect heart health
11.628) compared with dulaglutide, resulting in an ICER of 174,904 per QALY gained
Back De Herder, W, Klppel, G (28 July 2023) 'One hundred years after the discovery of insulin and glucagon: the history of tumors and hyperplasias that hypersecrete these hormones', Endocrine-Related Cancer , 30/9